Brineura Being Tested in Eyes of Children With CLN2
Brineura (cerliponase alfa) — a therapy developed by BioMarin for late infantile Batten disease that is typically infused directly into the brain — is being administered into the eyes of a select group of children with the disorder as an attempt to prevent vision loss. The study,…